Catalent Pharma Solutions’ Post

With mammalian cell line engineering and flexible cGMP production scale up to 4,000L in single-use bioreactors, Catalent Biologics offers increased flexibility & manufacturing scale to support customer growth. This article features Justin Koepsel, PhD, MBA where he discusses how our Madison facility plays a role in Wisconsin’s biopharmaceutical manufacturing sector. #Wisconsin #biotech https://ow.ly/5QpZ50SqpyV

With mammalian cell line engineering and flexible cGMP production scale up to 4,000L in single-use bioreactors, Catalent Biologics offers increased flexibility & manufacturing scale to support customer growth. This article features Justin Koepsel, PhD, MBA where he discusses how our Madison facility plays a role in Wisconsin’s biopharmaceutical manufacturing sector. #Wisconsin #biotech https://ow.ly/7pEP50SxU6A https://dy.si/Pc2djS

With mammalian cell line engineering and flexible cGMP production scale up to 4,000L in single-use bioreactors, Catalent Biologics offers increased flexibility & manufacturing scale to support customer growth. This article features Justin Koepsel, PhD, MBA where he discusses how our Madison facility plays a role in Wisconsin’s biopharmaceutical manufacturing sector. #Wisconsin #biotech https://ow.ly/7pEP50SxU6A https://dy.si/KtH3L12

With mammalian cell line engineering and flexible cGMP production scale up to 4,000L in single-use bioreactors, Catalent Biologics offers increased flexibility & manufacturing scale to support customer growth. This article features Justin Koepsel, PhD, MBA where he discusses how our Madison facility plays a role in Wisconsin’s biopharmaceutical manufacturing sector. #Wisconsin #biotech https://ow.ly/7pEP50SxU6A https://bit.ly/3Sasat8

With mammalian cell line engineering and flexible cGMP production scale up to 4,000L in single-use bioreactors, Catalent Biologics offers increased flexibility & manufacturing scale to support customer growth. This article features Justin Koepsel, PhD, MBA where he discusses how our Madison facility plays a role in Wisconsin’s biopharmaceutical manufacturing sector. #Wisconsin #biotech https://ow.ly/7pEP50SxU6A https://bit.ly/3W5EtrN

With mammalian cell line engineering and flexible cGMP production scale up to 4,000L in single-use bioreactors, Catalent Biologics offers increased flexibility & manufacturing scale to support customer growth. This article features Justin Koepsel, PhD, MBA where he discusses how our Madison facility plays a role in Wisconsin’s biopharmaceutical manufacturing sector. #Wisconsin #biotech https://ow.ly/7pEP50SxU6A https://dy.si/DMnb8m

With mammalian cell line engineering and flexible cGMP production scale up to 4,000L in single-use bioreactors, Catalent Biologics offers increased flexibility & manufacturing scale to support customer growth. This article features Justin Koepsel, PhD, MBA where he discusses how our Madison facility plays a role in Wisconsin’s biopharmaceutical manufacturing sector. #Wisconsin #biotech https://ow.ly/7pEP50SxU6A https://bit.ly/4eX88Mm

With mammalian cell line engineering and flexible cGMP production scale up to 4,000L in single-use bioreactors, Catalent Biologics offers increased flexibility & manufacturing scale to support customer growth. This article features Justin Koepsel, PhD, MBA where he discusses how our Madison facility plays a role in Wisconsin’s biopharmaceutical manufacturing sector. #Wisconsin #biotech https://ow.ly/7pEP50SxU6A https://bit.ly/465qSoO

With mammalian cell line engineering and flexible cGMP production scale up to 4,000L in single-use bioreactors, Catalent Biologics offers increased flexibility & manufacturing scale to support customer growth. This article features Justin Koepsel, PhD, MBA where he discusses how our Madison facility plays a role in Wisconsin’s biopharmaceutical manufacturing sector. #Wisconsin #biotech https://ow.ly/7pEP50SxU6A https://dy.si/9mDcBP

With mammalian cell line engineering and flexible cGMP production scale up to 4,000L in single-use bioreactors, Catalent Biologics offers increased flexibility & manufacturing scale to support customer growth. This article features Justin Koepsel, PhD, MBA where he discusses how our Madison facility plays a role in Wisconsin’s biopharmaceutical manufacturing sector. #Wisconsin #biotech https://ow.ly/7pEP50SxU6A https://dy.si/FCcof